P. Todeschini

Latest

• Comprehensive profiling of hypoxia-related mirnas identifies mir-23a-3p overexpression as a marker of platinum resistance and poor prognosis in high-grade serous ovarian cancer
• Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer
• FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
• Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts